Welcome to Extreme Investor Network, where we provide unique insights and expert analysis on the latest trends in investing. Today, we are diving into Friday’s biggest calls on Wall Street to help you stay ahead of the curve.
Mizuho reiterated Nvidia as a buy, raising its price target to $132 per share from $127.50. This move comes ahead of NVDA earnings on Aug 28th, signaling potential upside for investors.
Morgan Stanley upgraded Third Harmonic to overweight, advising investors to buy the dip in shares of the biotech company. With visibility to potentially de-risking data early next year, there is room for growth.
Bank of America upgraded Yeti to buy, citing positive catalysts ahead for the lifestyle products outdoor company. With a raised price target of $55, there are multiple drivers of potential upside in the second half of the year.
At Canaccord, Vericel was initiated as a buy, highlighting the cell therapy company’s sustainable high growth and profitability. With a buy rating and a price target of $57, there is optimism for Vericel’s future trajectory.
These are just a few of the exciting developments in the investing world. Stay tuned to Extreme Investor Network for more expert analysis and unique insights to help you navigate the complex world of investing with confidence.